Delivery Order SPE2DB20D7066-SPE2DB25FC3NP
- Not listed
- The Defense Logistics Agency awarded a $3,210.88 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Ryanodex 250 mg vials, with an ultimate completion date of August 13, 2025. This non-set-aside contract was competitively awarded on July 23, 2025, with performance at the contractor's facility in Conshohocken, Pennsylvania. Ryanodex is a dantrolene sodium formulation used primarily for the acute treatment of malignant hyperthermia in surgical settings, representing a critical...
- The Defense Logistics Agency awarded a $9,632.64 delivery order to AmerisourceBergen Drug Corp for Ryanodex 250 mg vials under a firm fixed price contract. The award was announced on September 2, 2025, with an ultimate completion date of September 23, 2025. This delivery order carries no set-aside designation, indicating it was competitively awarded. Performance will occur at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a $1,601.07 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Ryanodex 250 mg vials, with an ultimate completion date of January 5, 2026. This competitively awarded, non-set-aside contract leverages AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.99 billion vehicle extending through December 2026. The place of performance is located in Conshohocken, Pennsylvania, where...
- The Defense Logistics Agency Troop Support Medical awarded a $14,290.90 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 250mg vials of ryanodex. The place of performance will be Amerisourcebergen's facility located in Conshohocken, Pennsylvania. The delivery order has a period of performance starting on September 7, 2023 through September 25, 2023. No major subcontractors or set aside designations were indicated. This delivery order appears to be fulfilling a...
- The Defense Logistics Agency awarded a delivery order valued at $9,606.42 to AmerisourceBergen Drug Corp for the supply of Ryanodex 250 mg vials, with performance to be completed by December 22, 2025. This competitively awarded, firm fixed-price delivery order was issued without a set-aside designation and will be fulfilled from the contractor's Conshohocken, Pennsylvania facility. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical vendor, serves as...
- This delivery order, valued at $52,979.52, awards AmerisourceBergen Drug Corp the contract to supply Ryanodex 250mg vials to support federal medical procurement needs. The award, issued on July 25, 2025, with an ultimate completion date of August 14, 2025, represents a firm fixed-price delivery order with no set-aside designation. The contract is performed from the vendor's location in Conshohocken, Pennsylvania, and is funded by the Defense Logistics Agency's Medical Supply Chain division,...
- The Defense Logistics Agency awarded a delivery order valued at $9,632.64 to AmerisourceBergen Drug Corp for Ryanodex 250 mg vials on September 26, 2025, with completion scheduled for October 20, 2025. This firm fixed price, competitively awarded delivery order represents a routine pharmaceutical procurement under the company's existing contract vehicle with DLA. The award was placed to AmerisourceBergen's corporate office located in Conshohocken, Pennsylvania, where the company maintains its...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of Ryanodex 250mg vials with a firm fixed price ceiling value of $57,795.84 and an ultimate completion date of August 18, 2025. This is a non-set-aside, competitively awarded contract. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical federal medical procurement vendor with an...
- The Defense Logistics Agency awarded a delivery order valued at $3,108.56 to AmerisourceBergen Drug Corp on December 9, 2025, for the supply of Ryanodex 250 mg vials. This is a firm fixed-price delivery order with an ultimate completion date of December 31, 2025, executed through an open competitive process with no set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement and maintains...
- This is a delivery order under a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen Drug Corp with the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $999,999,999, provides a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The specific delivery order is for 250 mg vials of the drug Ryanodex, with a ceiling value of $5,716.40. The order was awarded on April 12, 2023 and has a...
- SPE2DB20D7066Indefinite Delivery Contract
- SPE2DB20D7066-SPE2DB25FC3NPDelivery Order
The Defense Logistics Agency awarded a $12.8K delivery order to AmerisourceBergen Drug Corp for Ryanodex 250 mg vials on May 30, 2025, with completion scheduled for June 23, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Ryanodex is a brand-name medication indicated for the treatment of malignant hyperthermia, a rare but serious pharmacogenetic disorder that can occur during anesthesia and surgery. This delivery order falls under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999.999 billion and extending through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling the contractor to supply an extensive range of pharmaceutical products and medical commodities to support military healthcare programs worldwide. AmerisourceBergen Drug Corp's federal contract portfolio demonstrates consistent capability in fulfilling specialized medical supply requirements across multiple therapeutic domains for the Defense Health Agency and other government healthcare systems through competitive procurement processes.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $12.8k | 5/30/25 |